Atlas Trials

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Clinical trial NCT04508829 · UNKNOWN

Trial details

NCT number
NCT04508829
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharyngeal Carcinoma
Start date
2016-01-01
Primary completion
2023-12-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.